MEDTRONIC BEGINS CLINICAL TRIAL FOR CAROTID STENT.

Publication: Biotech Equipment Update

Bookmark this article Print this article Link to this article Email this article Digg It! Add to del.icio.us RSS

COPYRIGHT 2001 Worldwide Videotex

Demonstrating its commitment to the continued development of clinical solutions for the entire vascular system, Medtronic, Inc. (NYSE:MDT), Minneapolis, has started enrollment for its European clinical trials to evaluate the safety and performance of its self-expanding carotid stent. Medtronic has also received approval to begin its U.S. clinical trial Patient enrollment for this trial will begin shortly.

Carotid arteries are located on either side of the neck and serve as the main conduit for blood flow to the brain. When a blood clot or a free-floating piece of plaque...

Read the full article for free courtesy of your local library.